Related Experiment Videos
A new model of proliferative vitreoretinopathy
E M Frenzel1, K A Neely, A W Walsh
1Department of Ophthalmology, University of Minnesota, Minneapolis 55455, USA.
Investigative Ophthalmology & Visual Science
|October 7, 1998
Summary
Intraocular dispase injection successfully created a new rabbit model for proliferative vitreoretinopathy (PVR) without needing extra cells. This dispase-induced PVR model offers a reliable method for studying this condition.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pathogenesis Research
Background:
- Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment.
- The pathogenesis of PVR often involves the release and proliferation of endogenous cells.
- Existing models frequently require the addition of exogenous cells or factors.
Purpose of the Study:
- To develop a novel intraocular model of proliferative vitreoretinopathy (PVR).
- To investigate if dispase, a proteolytic enzyme, can induce PVR by releasing endogenous cells.
- To determine the necessity of a surgical retinal break for dispase-induced PVR.
Main Methods:
- Dutch Belted rabbits received subretinal or intravitreal injections of dispase (0.003-1.0 U) or saline.
- A controlled retinal break was surgically created in some experimental groups.
- Animals were observed for at least 10 weeks post-injection to monitor for PVR development.
Main Results:
- Intraocular dispase administration induced PVR, with or without a retinal break.
- Higher dispase doses correlated with increased PVR severity.
- Observed PVR features included preretinal membranes, distorted retinal vasculature, retinal folds, and tractional retinal detachment.
Conclusions:
- Dispase effectively models PVR without exogenous cells, growth factors, or cytokines.
- Dispase likely triggers an endogenous cellular cascade leading to PVR.
- The dispase model is technically straightforward, allows clear visualization, and demonstrates a high success rate for PVR induction.